絞り込み

16287

広告

768件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Paramagnetic micro-particles as a tool for rapid quantification of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma by UHPLC-MS/MS.

Oral anticoagulation in primary care.

The role of new oral anticoagulants in orthopaedics: an update of recent evidence.

Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial.

Deep Venous Thrombosis and Pulmonary Embolism: Current Therapy.

Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis.

External validation of the VTE-BLEED score for predicting major bleeding in stable anticoagulated patients with venous thromboembolism.

Risk-adapted management of pulmonary embolism.

Edoxaban treatment for pulmonary arterial thromboembolism associated with azygous vein aneurysm.

Short-Term Subcutaneous Fondaparinux and Oral Edoxaban for Acute Venous Thromboembolism.

[Edoxaban for stroke prevention in atrial fibrillation and treatment of venous thromboembolism: an expert position paper].

Effects on bone metabolism markers and arterial stiffness by switching to rivaroxaban from warfarin in patients with atrial fibrillation.

Managing patients taking edoxaban in dentistry.

Dental management of patients taking novel oral anticoagulants (NOAs): Dabigatran.

Edoxaban for the Prevention of Thromboembolism in Patients with AtrialFibrillation and Bioprosthetic Valves.

Reversal of Direct Oral Anticoagulants: Current Status and Future Directions.

Clinical implications of reversal agents for direct oral anticoagulants.

Unmet Needs in Anticoagulant Therapy: Potential Role of Rivaroxaban.

Old and new oral anticoagulants: Food, herbal medicines and drug interactions.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります